Similarly, MALAT1 abundance was greater in NAFLD patients with higher scores of ballooning degeneration, lobular inflammation, and presence of fibrosis, and was correlated with serum ALT and AST levels. Here, MALAT1 is linked to metabolic dysfunction-associated steatotic liver disease.